X T L Biopharmaceuticals reported $289K in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Bioline Rx USD 427K 123K Sep/2025
Teva Pharmaceutical Industries USD 14.63B 10M Dec/2025
X T L Biopharmaceuticals USD 289K 127K Dec/2024